Outcome in critically ill medical patients treated with renal replacement therapy for acute renal failure: comparison between patients with and those without haematological malignancies

被引:91
作者
Benoit, DD
Hoste, EA
Depuydt, PO
Offner, FC
Lameire, NH
Vandewoude, KH
Dhondt, AW
Noens, LA
Decruyenaere, JM
机构
[1] Ghent Univ Hosp, Med Intens Care Unit, Dept Internal Med, B-9000 Ghent, Belgium
[2] Ghent Univ Hosp, Intens Care Med Div, B-9000 Ghent, Belgium
[3] Ghent Univ Hosp, Div Hematol, B-9000 Ghent, Belgium
[4] Ghent Univ Hosp, Div Renal, B-9000 Ghent, Belgium
关键词
acute renal failure; haematological malignancy; infection; intensive care unit; renal replacement therapy;
D O I
10.1093/ndt/gfh637
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Starting renal replacement therapy (RRT) for acute renal failure in critically ill patients with haematological malignancies is controversial because of the poor outcome and high costs. The aim of this study was to compare the outcome between critically ill medical patients with and without haematological malignancies who received RRT for acute renal failure. Methods. We retrospectively collected data on all consecutive patients who received RRT for acute renal failure at the Medical Intensive Care Unit (ICU) of a University Hospital between 1997 and 2002, and assessed the impact of the presence of a haematological malignancy on the survival within 6 months after ICU admission by Cox proportional hazard models. Results. Fifty of the 222 (22.5%) consecutive patients with haematological malignancies admitted to the ICU over the study period received RRT for acute renal failure compared with 248 of the 4293 (5.8%) patients without haematological malignancies (P < 0.001). Among patients who received RRT, those with haematological malignancies had higher crude ICU (79.6 vs 55.7%, P=0.002) and in-hospital (83.7 vs 66.1%, P = 0.016) mortality rates, and a higher mortality at 6 months (86 vs 72%, P = 0.018) by Kaplan-Meier estimates compared with those without haematological malignancies. However, after adjustment for the severity of illness and the duration of hospitalization before ICU admission, haematological malignancy by itself was no longer associated with a higher risk of death (hazard ratio 1.04; 95% confidence interval, 0.73-1.54, P = 0.78). Conclusions. Medical ICU patients with haematological malignancies have a higher rate of occurrence of acute renal failure treated with RRT and a higher mortality, compared with those without haematological malignancies. However, the presence of a haematological malignancy by itself is not a reason to withhold RRT in medical ICU patients with acute renal failure.
引用
收藏
页码:552 / 558
页数:7
相关论文
共 20 条
  • [1] Improved survival in cancer patients requiring mechanical ventilatory support: Impact of noninvasive mechanical ventilatory support
    Azoulay, E
    Alberti, C
    Bornstain, C
    Leleu, G
    Moreau, D
    Recher, C
    Chevret, S
    Le Gall, JR
    Brochard, L
    Schlemmer, B
    [J]. CRITICAL CARE MEDICINE, 2001, 29 (03) : 519 - 525
  • [2] Benoit DD, 2004, CRIT CARE MED, V32, P307, DOI 10.1097/01.CCM.0000092451.35634.A9
  • [3] Outcome and early prognostic indicators in patients with a hematologic malignancy admitted to the intensive care unit for a life-threatening complication
    Benoit, DD
    Vandewoude, KH
    Decruyenaere, JM
    Hoste, EA
    Colardyn, FA
    [J]. CRITICAL CARE MEDICINE, 2003, 31 (01) : 104 - 112
  • [4] Acute renal failure in intensive care units - Causes, outcome, and prognostic factors of hospital mortality: A prospective, multicenter study
    Brivet, FG
    Kleinknecht, DJ
    Loirat, P
    Landais, PJM
    Bedock, B
    Bleichner, G
    Richard, C
    Coste, F
    BrunBuisson, C
    Sicot, C
    Tenaillon, A
    Gajdos, P
    Blin, F
    Saulnier, F
    Agostini, MM
    Nicolas, F
    FeryLemonnier, E
    Staikowski, F
    Carlet, J
    Guivarch, G
    Fraisse, F
    Ricome, J
    Tempe, JD
    Mezzarobba, P
    [J]. CRITICAL CARE MEDICINE, 1996, 24 (02) : 192 - 198
  • [5] IS INTENSIVE-CARE JUSTIFIED FOR PATIENTS WITH HEMATOLOGICAL MALIGNANCIES
    BRUNET, F
    LANORE, JJ
    DHAINAUT, JF
    DREYFUS, F
    VAXELAIRE, JF
    NOUIRA, S
    GIRAUD, T
    ARMAGANIDIS, A
    MONSALLIER, JF
    [J]. INTENSIVE CARE MEDICINE, 1990, 16 (05) : 291 - 297
  • [6] PROGNOSTIC STRATIFICATION IN CRITICALLY ILL PATIENTS WITH ACUTE-RENAL-FAILURE REQUIRING DIALYSIS
    CHERTOW, GM
    CHRISTIANSEN, CL
    CLEARY, PD
    MUNRO, C
    LAZARUS, JM
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1995, 155 (14) : 1505 - 1511
  • [7] Acute renal failure in the ICU:: risk factors and outcome evaluated by the SOFA score
    de Mendonça, A
    Vincent, JL
    Suter, PM
    Moreno, R
    Dearden, NM
    Antonelli, M
    Takala, J
    Sprung, C
    Cantraine, F
    [J]. INTENSIVE CARE MEDICINE, 2000, 26 (07) : 915 - 921
  • [8] Multicenter outcome study of cancer patients admitted to the intensive care unit: A probability of mortality model
    Groeger, JS
    Lemeshow, S
    Price, K
    Nierman, DM
    White, P
    Klar, J
    Granovsky, S
    Horak, D
    Kish, SK
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (02) : 761 - 770
  • [9] Intensive care, mechanical ventilation, dialysis, and cardiopulmonary resuscitation - Implications for the patient with cancer
    Groeger, JS
    Aurora, RN
    [J]. CRITICAL CARE CLINICS, 2001, 17 (03) : 791 - +
  • [10] Severe respiratory failure requiring ICU admission in bone marrow transplant recipients
    Gruson, D
    Hilbert, G
    Portel, L
    Boiron, JM
    Bebear, CM
    Vargas, F
    Bebear, C
    Reiffers, J
    Gbikpi-Benissan, G
    Cardinaud, JP
    [J]. EUROPEAN RESPIRATORY JOURNAL, 1999, 13 (04) : 883 - 887